RBC
QHC

Roble Belko & Company’s Quorum Health Corporation QHC Stock Holding History

Roble Belko & Company’s Portfolio QHC Stock Details QHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-453
Closed -$3K – 436
2016
Q3 		$3K Buy
+453
New +$3.71K ﹤0.01% 270

Other funds holding QHC

GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACM
Accipiter Capital Management Palm Beach Gardens, Florida $124M AUM 6.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Roble Belko & Company's QHC Position: Q4 2016 in Review

Roble Belko & Company sold out of Quorum Health Corporation (QHC) in Q4 2016, closing a stake of 453 shares — an estimated $3K sold.

Roble Belko & Company first reported a position in QHC in Q3 2016 and held it in 1 quarter. The position peaked at $3K in Q3 2016. 160 funds tracked by Wall St. Rank hold QHC as of Q4 2016.

  • Roble Belko & Company reported no remaining Quorum Health Corporation position as of Q4 2016 after selling out during the quarter.
  • Roble Belko & Company sold 453 Quorum Health Corporation shares in Q4 2016, an estimated $3K.
  • Roble Belko & Company first reported a position in Quorum Health Corporation in Q3 2016 and held it in 1 quarter.
  • Roble Belko & Company's Quorum Health Corporation position peaked at $3K in Q3 2016.
  • 160 funds tracked by Wall St. Rank held Quorum Health Corporation as of Q4 2016.

Based on Roble Belko & Company's 13F filing for Q4 2016, filed 18 Jan 2017.